A phase III trial of PPP001 (smokeable marijuana) in terminal cancer patients
Phase of Trial: Phase III
Latest Information Update: 13 Jun 2018
At a glance
- Drugs Marijuana (Primary)
- Indications Cancer pain; Neuropathic pain
- Focus Registrational; Therapeutic Use
- Sponsors Tetra Bio Pharma
- 13 Jun 2018 According to a Tetra Bio Pharma media release, the company expects to complete this trial in Q4 of 2018 or Q1 of 2019 and will file for approval in Q1 of 2019.
- 04 Apr 2018 According to a Tetra Bio Pharma media release, this trial will be used o support the marketing application of PPP001 smokable pellet that is followed by four other cannabinoid-based products that we are developing using different delivery systems such as oral tablets, eye drops, topical ointments and oral capsules of cannabis oil.
- 04 Apr 2018 Status changed from planning to recruiting, according to the Tetra Bio Pharma media release.